BestNovo (Jiangsu) Medical Technology Co 

BestNovo (Jiangsu) Medical Technology Co is a pioneer in the development of precision cardiovascular and cerebrovascular medicine in China and a national high-tech enterprise. It has 15 years of experience in the development of disease control diagnostic products.

It led the development and application of the first H1N1 virus detection kit in China and has more than 100 virus and pathogen detection products. 

E-Town Financing Guarantee has provided a financing guarantee amounting to 1 million yuan for the company. 

After the epidemic outbreak, the company started  emergency procedures as soon as possible and developed the "novel coronavirus pneumonia (2019-nCoV) nucleic acid detection kit (fluorescent PCR method)" in less than 20 hours and passed the registration inspection of Jiangsu province, with a production capacity of 100,000 kits.

BestNovo has donated 20,000 novel coronavirus pneumonia detection kits in batches to key epidemic-stricken areas in places -- including Hubei, Zhejiang, and Chongqing -- to fight the epidemic, as well as to designated hospitals in Beijing to help with the diagnosis and timely treatment of patients with the coronavirus.